Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]
Han L +5 more
europepmc +1 more source
Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis. [PDF]
Zhang S, Sun T, Song L, Jin X, Li B.
europepmc +1 more source
What the European Reference Network Registry for Rare Liver Diseases Tells Us About Primary Biliary Cholangitis in European Practice. [PDF]
Lantinga MA.
europepmc +1 more source
Does Pemafibrate Lower Low-Density Lipoprotein-Cholesterol? [PDF]
Fujioka Y.
europepmc +1 more source
Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue. [PDF]
Moldovan I +4 more
europepmc +1 more source
Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor. [PDF]
Jamal F +11 more
europepmc +1 more source
Narrative Review of Management Strategies and Risk Mitigation for Gastrointestinal Bleeding in Atrial Fibrillation Patients Receiving Warfarin. [PDF]
Soltani AS +7 more
europepmc +1 more source
Autoimmune liver diseases in Latin America: Current landscape and challenges. [PDF]
Couto CA +6 more
europepmc +1 more source
Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes. [PDF]
Abdul Wahab R, Wan Mahmood WA.
europepmc +1 more source

